6922 — Cryofocus Medtech Shanghai Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.92bn
- HK$1.83bn
- CNY40.95m
Annual cashflow statement for Cryofocus Medtech Shanghai Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -159 | -126 | -118 | -106 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 111 | 67.3 | 17.9 | 19.4 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 11.2 | -7.76 | -4.2 | -18.9 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -34.2 | -62.5 | -96.9 | -95.9 |
| Capital Expenditures | -1.51 | -12.5 | -7.01 | -15.1 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 28.5 | 28.2 | 0.463 | — |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 27 | 15.7 | -6.55 | -15.1 |
| Financing Cash Flow Items | 0 | -4.37 | -15.2 | -8.24 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -0.608 | 198 | 169 | -13.7 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -7.89 | 150 | 68.6 | -123 |